• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Reduced skin homing by functional Treg in vitiligo.白癜风中功能性 Treg 减少皮肤归巢。
Pigment Cell Melanoma Res. 2010 Apr;23(2):276-86. doi: 10.1111/j.1755-148X.2010.00688.x. Epub 2010 Feb 19.
2
The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors.大多数人类外周血CD4+CD25高表达Foxp3+调节性T细胞带有功能性皮肤归巢受体。
J Immunol. 2006 Oct 1;177(7):4488-94. doi: 10.4049/jimmunol.177.7.4488.
3
Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.活动期泛发性白癜风患者调节性 T 细胞及程序性死亡受体 1 表达的调节性 T 细胞的改变及其临床相关性。
Br J Dermatol. 2015 Apr;172(4):940-50. doi: 10.1111/bjd.13511. Epub 2015 Feb 27.
4
Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo.补充调节性T细胞以阻止白癜风的色素脱失
J Investig Dermatol Symp Proc. 2017 Oct;18(2):S38-S45. doi: 10.1016/j.jisp.2016.10.023.
5
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.CD4(+)CD25(+)调节性T细胞独特的趋化反应谱及趋化因子受体CCR4和CCR8的特异性表达。
J Exp Med. 2001 Sep 17;194(6):847-53. doi: 10.1084/jem.194.6.847.
6
Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.人类外周血CD4+CD25+抑制性T细胞上皮肤与肠道偏向性归巢受体表达及内在CCR4表达
Eur J Immunol. 2003 Jun;33(6):1488-96. doi: 10.1002/eji.200323658.
7
CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.常见变异型免疫缺陷患儿的CD4+CD25+Foxp3+调节性T细胞、Th1(CCR5、IL-2、IFN-γ)和Th2(CCR4、IL-4、Il-13)型趋化因子受体及细胞内细胞因子
Int J Immunopathol Pharmacol. 2016 Jun;29(2):241-51. doi: 10.1177/0394632015617064. Epub 2015 Dec 18.
8
CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.CCL22可激活调节性T细胞迁移并抑制白癜风中的色素脱失。
J Invest Dermatol. 2015 Jun;135(6):1574-1580. doi: 10.1038/jid.2015.26. Epub 2015 Jan 9.
9
Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.活动性非节段型白癜风患者的调节性T细胞对CD8⁺CLA⁺T细胞的抑制能力较低。
Eur J Dermatol. 2014 Nov-Dec;24(6):676-82. doi: 10.1684/ejd.2014.2436.
10
Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.全身性白癜风患者的 CD8+ 细胞毒性 T 淋巴细胞的整体激活与调节性 T 细胞的损伤有关。
PLoS One. 2012;7(5):e37513. doi: 10.1371/journal.pone.0037513. Epub 2012 May 23.

引用本文的文献

1
Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications.调节性T细胞的组织特异性作用:抑制机制及其他,以及自身免疫性疾病中新兴的治疗见解
Front Immunol. 2025 Aug 26;16:1650451. doi: 10.3389/fimmu.2025.1650451. eCollection 2025.
2
Deciphering Depigmentation: Mouse Models for Vitiligo Research.解读色素脱失:白癜风研究的小鼠模型
J Invest Dermatol. 2025 Sep;145(9):2135-2146. doi: 10.1016/j.jid.2025.06.1582. Epub 2025 Jul 23.
3
Chromatin accessibility profiling of Treg cells in acute urticaria.急性荨麻疹中调节性T细胞的染色质可及性分析
Epigenetics. 2025 Dec;20(1):2503126. doi: 10.1080/15592294.2025.2503126. Epub 2025 May 12.
4
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases.用于自身免疫性疾病和其他非肿瘤性疾病的工程化T细胞免疫疗法的进展。
Biomark Res. 2025 Feb 4;13(1):23. doi: 10.1186/s40364-025-00736-8.
5
Vitiligo: From Pathogenesis to Treatment.白癜风:从发病机制到治疗
J Clin Med. 2024 Sep 3;13(17):5225. doi: 10.3390/jcm13175225.
6
Topical application of simvastatin acid sodium salt and atorvastatin calcium salt in vitiligo patients. Results of the randomized, double-blind EVRAAS pilot study.辛伐他汀酸单钠盐和阿托伐他汀钙盐在白癜风患者中的局部应用。随机、双盲 EVRAAS 初步研究结果。
Sci Rep. 2024 Jun 25;14(1):14612. doi: 10.1038/s41598-024-65722-w.
7
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.调节性 T 细胞在白癜风中的作用及治疗进展:迷你综述。
Inflamm Res. 2024 Aug;73(8):1311-1332. doi: 10.1007/s00011-024-01900-w. Epub 2024 Jun 5.
8
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.白癜风样病变作为非小细胞肺癌免疫治疗反应的预测因子:来自大学中心的全面回顾和病例系列。
Curr Oncol. 2024 Feb 19;31(2):1113-1128. doi: 10.3390/curroncol31020083.
9
Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo.单细胞转录组学揭示非节段性白癜风的外周免疫反应。
Front Immunol. 2023 Nov 22;14:1221260. doi: 10.3389/fimmu.2023.1221260. eCollection 2023.
10
Regulatory T cells in skin regeneration and wound healing.皮肤再生和伤口愈合中的调节性 T 细胞。
Mil Med Res. 2023 Oct 23;10(1):49. doi: 10.1186/s40779-023-00484-6.

本文引用的文献

1
IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.银屑病中的白细胞介素-6信号传导可防止调节性T细胞介导的免疫抑制。
J Immunol. 2009 Sep 1;183(5):3170-6. doi: 10.4049/jimmunol.0803721. Epub 2009 Jul 31.
2
Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.调节性(FOXP3+)T细胞作为宫颈上皮内瘤变和宫颈癌免疫治疗的靶点。
Cancer Sci. 2009 Jun;100(6):1112-7. doi: 10.1111/j.1349-7006.2009.01153.x.
3
Familial coexisting and colocalized psoriasis and vitiligo responding to alefacept.家族性共存且共定位的银屑病和白癜风对阿法西普有反应。
J Cutan Med Surg. 2009 May-Jun;13(3):172-5. doi: 10.2310/7750.2008.08023.
4
Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.在神经转基因小鼠中,DNA疫苗接种和调节性T细胞耗竭后的肿瘤消退会导致自身免疫风险增加。
J Immunol. 2009 May 1;182(9):5873-81. doi: 10.4049/jimmunol.0804074.
5
Immunosuppression may be present within condyloma acuminata.尖锐湿疣内可能存在免疫抑制。
J Am Acad Dermatol. 2008 Dec;59(6):967-74. doi: 10.1016/j.jaad.2008.08.011.
6
Contact leukoderma after application of a compounded phenol cream and narrowband-UVB.
Eur J Dermatol. 2008 Sep-Oct;18(5):593-5. doi: 10.1684/ejd.2008.0481.
7
CD4 T cells: fates, functions, and faults.CD4 T细胞:命运、功能与缺陷
Blood. 2008 Sep 1;112(5):1557-69. doi: 10.1182/blood-2008-05-078154.
8
Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.系统性红斑狼疮中CD4+CD25+调节性T细胞的频率和迁移能力改变
Rheumatology (Oxford). 2008 Jun;47(6):789-94. doi: 10.1093/rheumatology/ken108. Epub 2008 Apr 3.
9
HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.HSP70i可加速自身免疫性白癜风小鼠模型的色素脱失。
J Invest Dermatol. 2008 Aug;128(8):2041-8. doi: 10.1038/jid.2008.45. Epub 2008 Mar 13.
10
Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.急性丙型肝炎病毒感染期间FoxP3 + CD4 + CD25(高表达)调节性T细胞的功能抑制
J Infect Dis. 2008 Jan 1;197(1):46-57. doi: 10.1086/523651.

白癜风中功能性 Treg 减少皮肤归巢。

Reduced skin homing by functional Treg in vitiligo.

机构信息

Departments of Pathology, Microbiology and Immunology/Oncology Institute, Loyola University Chicago, IL, USA.

出版信息

Pigment Cell Melanoma Res. 2010 Apr;23(2):276-86. doi: 10.1111/j.1755-148X.2010.00688.x. Epub 2010 Feb 19.

DOI:10.1111/j.1755-148X.2010.00688.x
PMID:20175879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3778930/
Abstract

In human vitiligo, cutaneous depigmentation involves cytotoxic activity of autoreactive T cells. It was hypothesized that depigmentation can progress in the absence of regulatory T cells (Treg). The percentage of Treg among skin infiltrating T cells was evaluated by immunoenzymatic double staining for CD3 and FoxP3, revealing drastically reduced numbers of Treg in non-lesional, perilesional and lesional vitiligo skin. Assessment of the circulating Treg pool by FACS analysis of CD4, CD25, CD127 and FoxP3 expression, and mixed lymphocyte reactions in presence and absence of sorted Treg revealed no systemic drop in the abundance or activity of Treg in vitiligo patients. Expression of skin homing receptors CCR4, CCR5, CCR8 and CLA was comparable among circulating vitiligo and control Treg. Treg from either source were equally capable of migrating towards CCR4 ligand and skin homing chemokine CCL22, yet significantly reduced expression of CCL22 in vitiligo skin observed by immunohistochemistry may explain failure of circulating, functional Treg to home to the skin in vitiligo. The paucity of Treg in vitiligo skin is likely crucial for perpetual anti-melanocyte reactivity in progressive disease.

摘要

在人类白癜风中,皮肤色素脱失涉及自身反应性 T 细胞的细胞毒性活性。据推测,在没有调节性 T 细胞(Treg)的情况下,色素脱失也可能进展。通过免疫酶双重染色 CD3 和 FoxP3 评估皮肤浸润性 T 细胞中的 Treg 百分比,发现非皮损、皮损周围和皮损白癜风皮肤中的 Treg 数量明显减少。通过流式细胞术分析 CD4、CD25、CD127 和 FoxP3 的表达以及存在和不存在分选的 Treg 的混合淋巴细胞反应来评估循环 Treg 池,并未发现白癜风患者中 Treg 的丰度或活性出现全身性下降。循环白癜风和对照 Treg 之间的皮肤归巢受体 CCR4、CCR5、CCR8 和 CLA 的表达无差异。来自任何来源的 Treg 都能够同样地向 CCR4 配体和皮肤归巢趋化因子 CCL22 迁移,但免疫组化观察到白癜风皮肤中 CCL22 的表达明显减少,可能解释了循环、功能性 Treg 未能在白癜风中归巢到皮肤的原因。白癜风皮肤中 Treg 的缺乏可能对进行性疾病中持续的抗黑素细胞反应至关重要。